References
- Arnaud CD. Hyperparathyroidism and renal failure. Kidney Int 1973; 4: 89–95
- Kuzela D C, Huffer W E, Craswell P W, Weil R. Soft tissue calcifications in chronic dialysis patients. Am J Pathol 1977; 86: 403–424
- Ibels L S, Alfrey A C, Huffer W E, Craswe UPW, Weil R. Calcification in end-stage kidneys. Am J Med 1981; 71: 33–37
- Clark I, Rivera-Cordero F. Prevention of phosphate-induced nephrocalcinosis by parathyroidectomy. Proc Soc Exp Biol Med 1972; 139: 803–805
- Borle A B, Clark I. Effects of phosphate-induced hyper-parathyroidism and parathyroidectomy on rat kidney calcium in vivo. Am J Physiol 1981; 241: E136–E141
- Klahr S, Slatopolsky E. Toxicity of parathyroid hormone in uremia. Ann Rev Med 1986; 37: 71–78
- Slatopolsky E, Caglar S, Renell J P, Taggart D D, Canterbury J M, Reiss E, Bricker N S. On the pathogeneis of hyperparathyroidism in chronic and experimental renal insufficiency in the dog. J Clin Invest 1971; 50: 492–499
- Massry S G, Arief A I, Coburn J W, Palniery G, Kleemann C R. Skeletal resistance to parathyroid hormone in renal failure: Study in 105 human subjects. Ann Intern Med 1973; 78: 357–363
- Fraser D R, Kodicek E. Unique biosynthesis by kidney of a biologically active vitamine D metabolite. Nature 1970; 228: 764–766
- Sommerville P J, Kaye M. Resistance to parathyroid hormone in renal failure: role of vitamine D metabolites. Kidney int 1978; 14: 245–254
- Silver J, Russell J, Sherwood L M. Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parthyroid cells. Proc Natl Acad Sci 1985; 82: 4270–4273
- Madsen S, Olgaard K, Ladefoged J. Suppressive effect of 1,25-(OH)22D3 on circulating parathyroid hormone in acute renal failure. J Clin Endocrinol Metab 1981; 53: 823–827
- Manchar N L, Retuta E, Jerome E. Protection from acute renal failure (ARF) by calcium channel blockers (CCBS) in humans. Kidney Int 1985; 27: 233–237
- Hertle L, Garthoff B. Calcium channel blocker nisoldipine limits ischemic damage in rat kidney. J Urology 1985; 134: 121–124
- Goldfarb D, Iaina A, Serban I, Gravendo S, Kapular S, Eliahou H E. Beneficial effect of verapamil in acute renal failure in the rat (41576). Proc Soc Exp Biol Med 1983; 172: 389–392
- Hirth C, Federmann S, Kazda S. The protective effect of the calcium antagonist nisoldipine in glycerol-induced renal failure. Diuretics. II. Chemistry, pharmacology and clinical applications, JB Puschett. Elsevier, Amsterdam 1987; pp. 490–493
- Hirth C, Federmann A, Garthoff B, Hertle L, Kazda S, Stasch J P. The effect of nisoldipine in experimentally induced renal failure. Nisoldipine, PG Hugenholtz, J Meyer. Springer, Berlin 1987; pp. 144–150
- Gattone V H, Evon A P, Mong S A, Connors B A, Arnoff G A, Luft FC. The morphology of the renal microvasculature in glycerol-and gentamicin-induced acute renal failure. J Lab Clin Med 1983; 101: 183–195
- Kazda S, Garthoff B, Rämsch K D, Schlüter G. New drugs annual. Cardiovascular drugs, A Scriabine. Raven, New York 1983; pp. 243–258
- Thiel G, Brunner F, Wunderlich P, Huguenin M, Bienko B, Torhorst J, Peters-Haefeli L, Kirchertz E J, Peters G. Protection of rat kidneys against HgCl2-induced acute renal failure by induction of high urine flow without renin suppression. Kidney Int 1976; 10: S191–S200
- Lopez-Hilker S, Galceran T, Chan Y L, Rapp N, Martin J, Slatopolsky E. Hypocalcemia may not be essential for the development of secondary hyperparthyroidism in chronic renal failure. J Clin Invest 1986; 78: 1097–1102
- Steinhausen M, Fleming J T, Parekh N. Nitrendipine and the pressure-dependent vasodilatation of vessels in the hydronephrotic kidney. J Cardiovasc Pharmacol 1987; 9(Suppl. 1): S39–S43
- Mason I, Welsh I, Torhorst J. The contribution of vascular obstruction to the functional defect that follows renal ischaemia. Kidney Int 1987; 31: 65–71
- Lee S M, Michael U F. The protective effect of nitrendipine on gentamycine-induced acute renal failure in rats. Exp Mol Pathol 1985; 43: 107–114